In summer 2023, its likely that Mounjaro (known as tirzepatide generically) will be officially approved by the FDA for weight loss as well (it seems to be one more large study on safety and efficacy away)
Schultz EN, Devadason SG, Khoo SK, Zhang G, Bizzintino JA, Martin AC, et al
The interview schedule was developed through discussion with healthcare professionals including a clinician working in a tier 3 obesity service, a diabetes physician, and a psychiatrist specialising in diabetes and mental health, as well as a member of the public with lived experience of taking a GLP-1 receptor agonist (see supplementary material p3)
, use the top part of the plunger seal to measure the appropriate volume)
PubMed laboratory research record [PMID: 12168778] PubMed record related to this compound for laboratory literature review
Consulting with a professional medical aesthetician will provide clarity and guide you toward the best treatment option